版本:
中国

BRIEF-Ovid Therapeutics Q1 loss per share $3.48

June 13 Ovid Therapeutics Inc:

* Ovid Therapeutics reports first quarter 2017 financial results and recent corporate progress

* Q1 loss per share $3.48

* Q1 earnings per share view $-0.87 -- Thomson Reuters I/B/E/S

* Ovid Therapeutics Inc says company expects topline data to evaluate ov101 to be available in second half of 2017. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐